Harvard Bioscience (HBIO) Net Shares Issued and Repurchased (2017 - 2026)

Harvard Bioscience (HBIO) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $2.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 100.0% year-over-year to $2.0 in Q1 2026; TTM through Mar 2026 was $2.0, a 100.0% decrease from a year earlier, with the FY2025 full-year figure at $663445.0, up 699.11% from the prior year.
• Net Shares Issued and Repurchased was $2.0 for Q1 2026 at Harvard Bioscience, down from $663445.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $663445.0 in Q4 2025 and troughed at $2.0 in Q1 2026.
• A 5-year average of $121734.9 and a median of $73896.0 in 2025 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased jumped 834.13% in 2023 and sank 100.0% in 2026, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $125773.0 in 2022, then decreased by 19.64% to $101065.0 in 2023, then dropped by 17.85% to $83023.0 in 2024, then jumped by 699.11% to $663445.0 in 2025, then slumped by 100.0% to $2.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $2.0 (Q1 2026), $663445.0 (Q4 2025), and $73896.0 (Q1 2025), per Business Quant data.